Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4213852
Max Phase: Preclinical
Molecular Formula: C19H13F4N3O4
Molecular Weight: 423.32
Molecule Type: Small molecule
Associated Items:
ID: ALA4213852
Max Phase: Preclinical
Molecular Formula: C19H13F4N3O4
Molecular Weight: 423.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)c1cc(=O)c2cc(NC(=O)Nc3cc(F)cc(C(F)(F)F)c3)ccc2[nH]1
Standard InChI: InChI=1S/C19H13F4N3O4/c1-30-17(28)15-8-16(27)13-7-11(2-3-14(13)26-15)24-18(29)25-12-5-9(19(21,22)23)4-10(20)6-12/h2-8H,1H3,(H,26,27)(H2,24,25,29)
Standard InChI Key: WWUYSOSZRDJVGE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 423.32 | Molecular Weight (Monoisotopic): 423.0842 | AlogP: 4.12 | #Rotatable Bonds: 3 |
Polar Surface Area: 100.29 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.66 | CX Basic pKa: | CX LogP: 4.12 | CX LogD: 4.12 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.44 | Np Likeness Score: -1.38 |
1. Ling T, Lang W, Feng X, Das S, Maier J, Jeffries C, Shelat A, Rivas F.. (2018) Novel vitexin-inspired scaffold against leukemia., 146 [PMID:29407975] [10.1016/j.ejmech.2018.01.004] |
Source(1):